contact us terms and disclaimers
links
  •  
  • investor information
  •  
  • products
  •  
  • science
  •  
  • company
  •  
  • home
  •  


  • Oct 2012 CANYON PHARMACEUTICALS’ DES...
    Jun 2012 KIDNEY DISEASE IS AN IMPORT...
    Oct 2011 Canyon Pharmaceuticals Hono...
    Aug 2011 DESIRABLE STUDY COMPLETED...
    May 2011 Study Finds Desirudin Super...

    About Us

    Investor Relations

    Product Information

    © Canyon Pharmaceuticals Group